Showing results (1851-1860 of 2,443) with videos related to

Sort By:
Pageof 245
Breast (Edinburgh, Scotland)|May 23, 2013
Risk factors associated with venous thromboembolism in 49,028 mastectomy patientsBrian H Tran, T JoAnna Nguyen, Brian H Hwang, et al.
The Journal of Arthroplasty|March 17, 2023
Gap Balancing Throughout the Arc of Motion With Navigated TKA and a Novel Force-Controlled Distractor: A Review of the First 273 CasesWen Fan, Laurent D Angibaud, Amaury Y Jung, et al.
British Journal of Pharmacology|March 19, 2003
Neurogenic responses mediated by vanilloid receptor-1 (TRPV1) are blocked by the high affinity antagonist, iodo-resiniferatoxinMichela Rigoni, Marcello Trevisani, David Gazzieri, et al.
Journal of the National Cancer Institute|January 4, 1995
Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastasesE Alexander, T M Moriarty, R B Davis, et al.
Brain : a Journal of Neurology|June 1, 1993
Linkage analysis in British and French families with idiopathic torsion dystoniaT T Warner, N A Fletcher, M B Davis, et al.
Molecular Phylogenetics and Evolution|May 14, 2021
Molecular phylogeny, classification, biogeography and diversification patterns of a diverse group of moths (Geometridae: Boarmiini)Leidys Murillo-Ramos, Nicolas Chazot, Pasi Sihvonen, et al.
International Journal of Oncology|April 14, 1999
A study of 9-nitrocamptothecin (RFS-2000) in patients with advanced pancreatic cancerJ S Stehlin, B C Giovanella, E A Natelson, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 29, 2000
Comparative pharmacodynamics of keliximab and clenoliximab in transgenic mice bearing human CD4A Sharma, C B Davis, L A Tobia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1989
Polymorphic residues on the I-A beta chain modulate the stimulation of T cell clones specific for the N-terminal peptide of the autoantigen myelin basic proteinC B Davis, D J Mitchell, D C Wraith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium studyNancy B Davis, David A Taber, Rafat H Ansari, et al.
Pageof 245